Search Results for citation:"90 FR 17080"

The Drug Enforcement Administration (DEA) has revoked the Certificate of Registration of De Novo Services, LLC, a company in Utah, due to numerous violations. The company failed to maintain effective controls and suitable record-keeping for controlled substances, putting public safety at risk. Despite multiple inspections and warnings, De Novo Services admitted to allowing unauthorized individuals to handle controlled substances and not properly documenting these transactions, among other issues. The DEA determined that revoking the registration was necessary both to address the violations and to serve as a deterrent to similar actions by others in the future.

The Expeditionary Missions Consortium—Crane (EMC2) has sent notifications to the Attorney General and the Federal Trade Commission about changes in its membership to limit antitrust plaintiffs' recovery to actual damages under certain conditions. Several companies, including AForge LLC, Booz Allen Hamilton, Inc., and Lockheed Martin Aerostructures, are new members, while Plasan North America, Inc. has left the consortium. EMC2 plans to continue updating its membership changes as needed and remains open to new members. This filing follows previous notifications in line with the National Cooperative Research and Production Act of 1993, with the latest notice being published in the Federal Register.